Robert Lisicki

Robert Lisicki

Corporate Officer/Principal at ARCUTIS BIOTHERAPEUTICS, INC.

Net worth: 2 M $ as of 31/10/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Robert Lisicki is Chief Commercial Officer & Executive VP at Arcutis Biotherapeutics, Inc. since 2026.
Formerly, Mr. Lisicki was Chief Executive Officer & Director at Zura Bio Ltd. from 2024 to 2025, Independent Director at Cadrenal Therapeutics, Inc. from 2023 to 2025, Director at Adiso Therapeutics, Inc. from 2023 to 2024, Chief Executive Officer & Director at InCarda Therapeutics, Inc. from 2022 to 2023, Chief Commercial Officer & Executive VP at Arena Pharmaceuticals, Inc. from 2018 to 2022, Chief Customer Officer, SVP-Sales & Marketing at Daiichi Sankyo, Inc. from 2014 to 2018, Vice President & General Manager at Amgen, Inc. from 2005 to 2014, and General Manager & Vice President-Cardio Metabolic at Regeneron Pharmaceuticals, Inc. Education includes undergraduate studies at State University of New York at Albany.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/11/2026 55,000 ( 0.04% ) 2 M $ 31/10/2026
20/04/2026 0 ( -.--% ) - $ 31/10/2026

Robert Lisicki active positions

CompaniesPositionStart
ARCUTIS BIOTHERAPEUTICS, INC. Corporate Officer/Principal 17/08/2026

Former positions of Robert Lisicki

CompaniesPositionEnd
ZURA BIO LIMITED Chief Executive Officer 10/10/2025
CADRENAL THERAPEUTICS, INC. Director/Board Member 15/07/2025
Director/Board Member 01/08/2024
Chief Executive Officer 01/03/2023
ARENA PHARMACEUTICALS Corporate Officer/Principal 01/03/2022
See the detail of Robert Lisicki's experience

Education of Robert Lisicki

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert Lisicki